CAMP - cathelicidin antimicrobial peptide Gene
Also Known as CATHL7
Species: Bos taurus
Gene Type: protein coding
Gene ID: 317650
CAMP Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_174831.2 | NP_777256.1 | cathelicidin-7 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cathelicidin-7 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(46)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0764 | Bucladesine sodium | Activator | 99.36% | Yes |
| HY-13749 | Sitagliptin | Inhibitor | 99.94% | Yes |
| HY-Y0682 | Ethylenediaminetetraacetic acid | 98.29% | Unkown | |
| HY-15498 | Rimegepant | Antagonist | 99.99% | Unkown |
| HY-P0036 | Octreotide | 99.96% | Unkown | |
| HY-14773 | Mirabegron | Agonist | 99.81% | Yes |
| HY-14302 | Salmeterol | Agonist | 99.69% | Yes |
| HY-13749A | Sitagliptin phosphate | Inhibitor | 99.88% | Yes |
| HY-B0764A | Bucladesine hemicalcium | 98.58% | Yes | |
| HY-119708 | Ensifentrine | Inhibitor | 99.36% | Unkown |
| HY-108742 | Abaloparatide | Activator | 99.82% | Unkown |
| HY-14300A | Vilanterol trifenatate | Agonist | 99.82% | Unkown |
| HY-12366 | Ubrogepant | Antagonist | 99.90% | Unkown |
| HY-17592 | Bithionol | Inhibitor | 99.32% | Unkown |
| HY-B0679 | Lubiprostone | 99.09% | Yes | |
| HY-17034B | Medetomidine hydrochloride | Agonist | 99.87% | Unkown |
| HY-13749B | Sitagliptin phosphate monohydrate | Inhibitor | 99.83% | Yes |
| HY-17453 | Salmeterol xinafoate | Agonist | 99.88% | Yes |
| HY-B1898 | Metadoxine | 99.88% | Yes | |
| HY-14300 | Vilanterol | Agonist | 99.30% | Unkown |
| HY-108742A | Abaloparatide TFA | Activator | 98.80% | Unkown |
| HY-17034 | Medetomidine | Agonist | 99.97% | Unkown |
| HY-B1481 | Isoetharine mesylate | Agonist | 99.05% | Unkown |
| HY-B0531 | Triflusal | 99.56% | Unkown | |
| HY-106539 | Colesevelam hydrochloride | 98.00% | Unkown | |
| HY-B1505 | Acefylline | 99.52% | Unkown | |
| HY-B1639 | Enoximone | Inhibitor | 99.91% | Unkown |
| HY-128932 | Cefminox sodium | 99.83% | Unkown | |
| HY-156131 | Loperamide | Agonist | 99.85% | Unkown |
| HY-B0327 | Irsogladine | 99.88% | Unkown | |
| HY-B1009 | Ethylenediaminetetraacetic acid trisodium salt | 98.0% | Unkown | |
| HY-B1209 | Etofylline | Inhibitor | 99.72% | Unkown |
| HY-B0813 | Treprostinil diethanolamine | Agonist | 99.44% | Yes |
| HY-13749AR | Sitagliptin phosphate (Standard) | Inhibitor | 99.82% | Unkown |
| HY-B1428 | 2-Ethoxybenzamide | 99.82% | Unkown | |
| HY-B0764R | Bucladesine sodium (Standard) | Activator | 99.81% | Unkown |
| HY-B1481A | Isoetharine | Agonist | / | Unkown |
| HY-114948 | Rimiterol | Agonist | / | Unkown |
| HY-13749E | Sitagliptin hydrochloride | Inhibitor | / | Unkown |
| HY-17457 | Levalbuterol hemitartrate | 98.71% | Yes | |
| HY-B0764B | Bucladesine | / | Unkown | |
| HY-P0036B | Octreotide pamoate | / | Unkown | |
| HY-P3445 | Anrikefon | Agonist | / | Unkown |
| HY-12366R | Ubrogepant (Standard) | Antagonist | / | Unkown |
| HY-13749R | Sitagliptin (Standard) | Inhibitor | / | Unkown |
| HY-B1428R | 2-Ethoxybenzamide (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(38)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-W127774 | EDTA hydrate sodium | 97.0% | Phase 4 | |
| HY-W105700 | Ethylenediaminetetraacetic acid sodium hydrate | 98.0% | Phase 4 | |
| HY-116755 | Tiropramide | Inhibitor | / | Phase 4 |
| HY-W087947 | EDTA dihydrate tripotassium | 97.0% | Phase 4 | |
| HY-50906 | LY404039 | Agonist | 98.0% | Phase 3 |
| HY-106358 | Andolast free base | Inhibitor | 98.37% | Phase 3 |
| HY-119486A | (Rac)-Tavapadon | Agonist | 99.49% | Phase 3 |
| HY-16635 | Setipiprant | Antagonist | 98.23% | Phase 3 |
| HY-130786 | Denbufylline | Inhibitor | 99.92% | Phase 3 |
| HY-P0165B | Taspoglutide acetate | Agonist | / | Phase 3 |
| HY-105101 | Osutidine | Antagonist | / | Phase 3 |
| HY-16900 | Rolipram | Inhibitor | 99.87% | Phase 2 |
| HY-10301 | MK-3207 | Antagonist | 99.60% | Phase 2 |
| HY-14550 | TP-10 | Inhibitor | 99.95% | Phase 2 |
| HY-12472 | Balipodect | Inhibitor | 99.47% | Phase 2 |
| HY-12887 | Piclamilast | Inhibitor | 99.74% | Phase 2 |
| HY-12525 | LGD-6972 | Antagonist | 98.0% | Phase 2 |
| HY-100936 | Etazolate hydrochloride | 98.00% | Phase 2 | |
| HY-135490 | Reproterol | 98.94% | Phase 2 | |
| HY-19867A | Burixafor hydrobromide | Antagonist | 99.70% | Phase 2 |
| HY-16642A | LY2828360 | Agonist | 99.50% | Phase 2 |
| HY-109139 | Taminadenant | Antagonist | 99.84% | Phase 2 |
| HY-101189 | JNJ-39758979 | Antagonist | 99.71% | Phase 2 |
| HY-19436 | Solabegron | Agonist | 99.89% | Phase 2 |
| HY-128656 | LML134 | Agonist | 99.43% | Phase 2 |
| HY-106303 | YT 146 | Agonist | 99.72% | Phase 2 |
| HY-106137 | Tofimilast | Inhibitor | / | Phase 2 |
| HY-14869 | Revamilast | Inhibitor | / | Phase 2 |
| HY-19755 | S-5751 | Antagonist | / | Phase 2 |
| HY-19867 | Burixafor | Antagonist | / | Phase 2 |
| HY-120547 | UCB-11056 | / | Phase 2 | |
| HY-18978 | GR79236 | Agonist | 99.89% | Phase 1 |
| HY-147017 | GSK2556286 | Inhibitor | 99.70% | Phase 1 |
| HY-14340 | WAY-181187 | Agonist | 98.83% | Phase 1 |
| HY-123534 | CYT-1010 | Agonist | 99.28% | Phase 1 |
| HY-19946 | Eptapirone | Agonist | 99.91% | Phase 1 |
| HY-124371 | Amentoflavone hexaacetate | / | Phase 1 | |
| HY-19946A | Eptapirone fumarate | Agonist | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(659)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15371 | Forskolin | 99.92% | Unkown | |
| HY-12306 | 8-Bromo-cAMP sodium salt | 99.91% | Unkown | |
| HY-B1511 | Cyclic AMP | 99.95% | Yes | |
| HY-12306A | 8-Bromo-cAMP | 99.48% | Unkown | |
| HY-100927 | Ro 20-1724 | Inhibitor | 99.98% | Unkown |
| HY-P0221 | PACAP (1-38), human, ovine, rat | Inducer | 99.99% | Unkown |
| HY-100403 | Ro 67-7476 | Agonist | 99.69% | Unkown |
| HY-113402 | Gamma-glutamylcysteine | 98.53% | Unkown | |
| HY-P10138 | human GIP(3-30), amide | Antagonist | 99.76% | Unkown |
| HY-B1511A | Cyclic AMP sodium | 99.97% | Unkown | |
| HY-121835 | GLP-1R agonist 2 | Agonist | 99.57% | Unkown |
| HY-149164 | BTB09089 | Agonist | 99.39% | Unkown |
| HY-P1237 | C-Type Natriuretic Peptide (CNP) (1-22), human | Inhibitor | 99.84% | Unkown |
| HY-103254 | ML221 | 98.45% | Unkown | |
| HY-W040329 | 2'-Deoxyadenosine | 99.97% | Unkown | |
| HY-103193 | NKH477 | Activator | 99.86% | Unkown |
| HY-P1471 | Adrenomedullin (AM) (22-52), human | Antagonist | 99.61% | Unkown |
| HY-124696 | PU139 | Inhibitor | 99.51% | Unkown |
| HY-W140439 | 1-Oleoyl-sn-glycero-3-phosphocholine | 99.58% | Unkown | |
| HY-16558 | Butein | 99.64% | Unkown | |
| HY-122197 | ML339 | Antagonist | 99.88% | Unkown |
| HY-W012980 | Isovaleric acid | Activator | ≥98.0% | Unkown |
| HY-111673 | 8-CPT-Cyclic AMP sodium | 99.92% | Unkown | |
| HY-P1291 | PKI 14-22 amide,myristoylated | Inhibitor | 98.96% | Unkown |
| HY-100530D | Rp-cAMPS sodium salt | Antagonist | 99.69% | Unkown |
| HY-P4860 | Adropin (34-76) (human, mouse, rat) | 98.23% | Unkown | |
| HY-107543 | 8-pCPT-2′-O-Me-cAMP sodium | Activator | 99.81% | Unkown |
| HY-P10138A | human GIP(3-30), amide TFA | Antagonist | 96.90% | Unkown |
| HY-P3419 | PAMP-12 (unmodified) | 99.40% | Unkown | |
| HY-N6727 | Gliotoxin | 99.51% | Unkown | |
| HY-N2118 | Bilobetin | Activator | 99.71% | Unkown |
| HY-P0221C | PACAP (1-38) free acid | 99.94% | Unkown | |
| HY-125791 | cis-Epoxysuccinic acid | Agonist | 98.0% | Unkown |
| HY-Y0682A | Ethylenediaminetetraacetic acid disodium dihydrate | 99.9% | Unkown | |
| HY-P6292A | KS-133 TFA | Antagonist | 98.95% | Unkown |
| HY-B1511R | Cyclic AMP (Standard) | 99.89% | Unkown | |
| HY-153660 | Bivamelagon | Agonist | 99.50% | Unkown |
| HY-162734 | BRD5075 | Activator | 98.08% | Unkown |
| HY-B0392 | (S)-(+)-Rolipram | 99.96% | Unkown | |
| HY-117656 | ESI-05 | Inhibitor | 99.78% | Unkown |
| HY-133529 | PA-8 | 97.00% | Unkown | |
| HY-P1291A | PKI 14-22 amide,myristoylated TFA | Inhibitor | 99.79% | Unkown |
| HY-P1852 | TIP 39, Tuberoinfundibular Neuropeptide | 99.84% | Unkown | |
| HY-128358 | MR-L2 | Activator | 98.63% | Unkown |
| HY-160734 | Aleniglipron | Agonist | 99.88% | Unkown |
| HY-P1023 | VIP(6-28)(human, rat, porcine, bovine) | Antagonist | 98.09% | Unkown |
| HY-103194 | KH7 | Inhibitor | 99.0% | Unkown |
| HY-P0222 | PKI(5-24) | Inhibitor | 99.99% | Unkown |
| HY-P2847 | Urocortin II, mouse | Agonist | 99.94% | Unkown |
| HY-P3366 | Ecnoglutide | Agonist | 99.93% | Unkown |
| HY-108539 | CE3F4 | Inhibitor | 98.85% | Unkown |
| HY-P0097A | Nonapeptide-1 acetate salt | Antagonist | 95.58% | Unkown |
| HY-112612A | RTI-13951-33 hydrochloride | 98.56% | Unkown | |
| HY-153967 | BLU0588 | Inhibitor | 97.63% | Unkown |
| HY-P1290A | PKA Inhibitor Fragment (6-22) amide TFA | Inhibitor | 99.77% | Unkown |
| HY-121615 | α-Phellandrene | Activator | 85.70% | Unkown |
| HY-P1298A | Sauvagine TFA | Agonist | 99.96% | Unkown |
| HY-129658A | TT-OAD2 | Agonist | 99.59% | Unkown |
| HY-124151 | Adenosine-2'-monophosphate | Activator | 99.91% | Unkown |
| HY-N0113 | Hordenine | Inhibitor | 99.88% | Unkown |
| HY-P0248 | Kemptide | 99.56% | Unkown | |
| HY-P2878 | Phosphodiesterase I | / | Unkown | |
| HY-135542 | NBI-27914 | Antagonist | 99.94% | Unkown |
| HY-18740A | Trequinsin hydrochloride | Inhibitor | 99.86% | Unkown |
| HY-103565 | AMN082 | Agonist | 99.73% | Unkown |
| HY-113402A | Gamma-glutamylcysteine TFA | 96.68% | Unkown | |
| HY-124717 | YC-001 | Antagonist | 99.43% | Unkown |
| HY-103431 | A68930 hydrochloride | Agonist | 98.71% | Unkown |
| HY-N0126 | Xanthone | Inhibitor | 99.97% | Unkown |
| HY-P1845 | PACAP-38 (31-38), human, mouse, rat | 98.93% | Unkown | |
| HY-110036 | GW-405833 | 98.91% | Unkown | |
| HY-111385 | UNC9994 hydrochloride | 99.50% | Unkown | |
| HY-136172 | ESI-08 | Antagonist | 98.74% | Unkown |
| HY-N3945 | Glaucine | 99.57% | Unkown | |
| HY-W011683 | 2'-Deoxyadenosine monohydrate | 99.89% | Unkown | |
| HY-147395 | GPR52 agonist-1 | Agonist | 99.76% | Unkown |
| HY-P10927 | BRP | 95.15% | Unkown | |
| HY-P2917 | Glycerol kinase, microorganism | Inhibitor | 98.00% | Unkown |
| HY-117958 | HJC0197 | Inhibitor | 99.62% | Unkown |
| HY-108618 | BC11-38 | Inhibitor | 99.42% | Unkown |
| HY-143312 | V-0219 | Modulator | 99.90% | Unkown |
| HY-175232 | GL64 | 98.80% | Unkown | |
| HY-P4127A | M65 TFA | Inhibitor | 99.98% | Unkown |
| HY-110218 | CW 008 | Agonist | 98.15% | Unkown |
| HY-14899 | Taprenepag | Agonist | 98.79% | Unkown |
| HY-N0910 | Notoginsenoside Ft1 | 99.49% | Unkown | |
| HY-N1860 | 3-O-Methylquercetin | Inhibitor | 99.98% | Unkown |
| HY-N2038 | 3,5,6,7,8,3',4'-Heptemthoxyflavone | Inhibitor | 99.86% | Unkown |
| HY-P1237A | C-Type Natriuretic Peptide (CNP) (1-22), human TFA | 99.07% | Unkown | |
| HY-B1511S | Cyclic AMP-13C5 | 97.45% | Unkown | |
| HY-19929 | Tanimilast | 99.71% | Unkown | |
| HY-100984 | HA-100 | Inhibitor | 99.87% | Unkown |
| HY-10797 | CJ-42794 | Antagonist | 98.96% | Unkown |
| HY-108626 | ML154 | Antagonist | 99.59% | Unkown |
| HY-119168 | LP-471756 | Antagonist | 99.53% | Unkown |
| HY-124571 | ZQ-16 | Agonist | 99.0% | Unkown |
| HY-147319 | RTI-7470-44 | Antagonist | 99.85% | Unkown |
| HY-15478 | WZ811 | Antagonist | 99.80% | Unkown |
| HY-P0172A | ATI-2341 TFA | Agonist | 98.08% | Unkown |
| HY-P4823 | pTH (1-37) (human) | Activator | 99.91% | Unkown |
| HY-101572 | MHP | Activator | 98.57% | Unkown |
| HY-103302 | SUN B8155 | Agonist | 99.89% | Unkown |
| HY-108539A | (R)-CE3F4 | Inhibitor | 99.3% | Unkown |
| HY-102076 | 0990CL | ≥98.0% | Unkown | |
| HY-107046 | UK-432097 | Agonist | 98.9% | Unkown |
| HY-131900 | Protein kinase inhibitor H-7 | Inhibitor | 99.96% | Unkown |
| HY-136637 | NPD-001 | Inhibitor | 98.11% | Unkown |
| HY-P0097 | Nonapeptide-1 | Antagonist | 98.74% | Unkown |
| HY-P1913A | Calcitonin Gene Related Peptide II (rat) TFA | Activator | 99.89% | Unkown |
| HY-111082 | ISAM-140 | Inhibitor | 99.13% | Unkown |
| HY-123335A | L-796778 acetate | Agonist | 98.00% | Unkown |
| HY-161106 | OX04528 | Agonist | 98.45% | Unkown |
| HY-18286 | NCGC00229600 | Antagonist | 99.67% | Unkown |
| HY-P1595 | CREBtide | Substrate | 98.33% | Unkown |
| HY-100530C | Sp-cAMPS sodium salt | 99.45% | Unkown | |
| HY-103547 | L-168049 | Antagonist | 99.94% | Unkown |
| HY-110206 | AM6545 | Antagonist | 99.32% | Unkown |
| HY-129421 | PA-9 | 99.73% | Unkown | |
| HY-P10365 | VPM-p15 | Agonist | 98.25% | Unkown |
| HY-P1106A | K41498 TFA | Antagonist | 98.71% | Unkown |
| HY-100013C | 2-PCCA hydrochloride | 99.61% | Unkown | |
| HY-14973 | Vidupiprant | Antagonist | 98.31% | Unkown |
| HY-103322 | 6-Bnz-cAMP sodium salt | 98.5% | Unkown | |
| HY-107580 | GPR109 receptor agonist-1 | Agonist | 99.94% | Unkown |
| HY-110036A | GW405833 hydrochloride | 99.59% | Unkown | |
| HY-163996 | DD202-114 | 99.27% | Unkown | |
| HY-P1065 | Apelin-36(rat, mouse) | 98.59% | Unkown | |
| HY-Y0682B | Ethylenediaminetetraacetic acid tetrasodium | Inhibitor | 98.0% | Unkown |
| HY-128879A | VP3.15 dihydrobromide | Inhibitor | 98.0% | Unkown |
| HY-103180 | 2'-MeCCPA | Agonist | 99.80% | Unkown |
| HY-103186 | MRS-1706 | Antagonist | 98.07% | Unkown |
| HY-116818 | Crebinostat | Inhibitor | 98.83% | Unkown |
| HY-145412 | GLP-1 receptor agonist 7 | Agonist | 98.17% | Unkown |
| HY-167856A | RTI-122 dihydrochloride | Agonist | 99.36% | Unkown |
| HY-P1845A | PACAP-38 (31-38), human, mouse, rat TFA | 99.30% | Unkown | |
| HY-P5189A | His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA | 99.94% | Unkown | |
| HY-100656 | Desmethyl cariprazine | Antagonist | 98.08% | Unkown |
| HY-101232 | Tiotidine | Antagonist | 99.28% | Unkown |
| HY-110003 | Arachidonylcyclopropylamide | Agonist | 99.9% | Unkown |
| HY-117829 | UNC9994 | 98.06% | Unkown | |
| HY-121793 | Roemerine | Inhibitor | 99.89% | Unkown |
| HY-139178 | KVA-D-88 | Inhibitor | 99.81% | Unkown |
| HY-176293 | EP2 receptor antagonist-3 | 99.08% | Unkown | |
| HY-N2168 | Pinoresinol 4-O-β-D-glucopyranoside | Inhibitor | 99.89% | Unkown |
| HY-P1296 | Urocortin, rat | Agonist | 99.23% | Unkown |
| HY-105118A | Zaldaride maleate | Antagonist | 99.7% | Unkown |
| HY-111527 | PPZ2 | 99.92% | Unkown | |
| HY-116530 | 9-Cyclopentyladenine monomethanesulfonate | Inhibitor | 99.95% | Unkown |
| HY-116874 | SKF 83822 | Agonist | 98.01% | Unkown |
| HY-131763 | 2'-O-MB-cAMP sodium | 99.95% | Unkown | |
| HY-134266 | 8-Bromo-AMP | 98.78% | Unkown | |
| HY-50158 | Glucagon receptor antagonist-2 | Antagonist | 99.23% | Unkown |
| HY-P10031 | SAR441255 | Agonist | 99.84% | Unkown |
| HY-P10716 | Exendin-P5 | Activator | 96.32% | Unkown |
| HY-P5275 | Tripeptide-41 | 99.30% | Unkown | |
| HY-113402R | Gamma-glutamylcysteine (Standard) | 98.14% | Unkown | |
| HY-P10031A | SAR441255 TFA | Agonist | 99.93% | Unkown |
| HY-P10336 | Serpinin | Agonist | 98.74% | Unkown |
| HY-RS16241 | Camp Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-111896 | 7-Methoxyrosmanol | Inhibitor | 99.28% | Unkown |
| HY-118941 | BAY 73-1449 | Antagonist | 98.40% | Unkown |
| HY-120511 | KNT-127 | Agonist | 99.11% | Unkown |
| HY-135119 | Salmeterol-d3 | Inhibitor | 98.04% | Unkown |
| HY-13749AS | Sitagliptin-d4 phosphate | Inhibitor | 99.48% | Unkown |
| HY-137640C | Rp-8-Br-cAMPS sodium | Inhibitor | 99.9% | Unkown |
| HY-143312A | V-0219 hydrochloride | Modulator | 99.39% | Unkown |
| HY-162735 | BRD5080 | Activator | 99.44% | Unkown |
| HY-163671 | PW0729 | 99.55% | Unkown | |
| HY-P1106 | K41498 | Antagonist | 99.66% | Unkown |
| HY-P1290 | PKA Inhibitor Fragment (6-22) amide | Inhibitor | 98.00% | Unkown |
| HY-N8593 | Undecane | 99.66% | Unkown | |
| HY-13749S1 | Sitagliptin-d4 hydrochloride | Inhibitor | 99.36% | Unkown |
| HY-123820 | LY3020371 hydrochloride | Antagonist | 99.18% | Unkown |
| HY-107544 | 8-pCPT-2'-O-Me-cAMP-AM | Activator | 99.7% | Unkown |
| HY-112465 | H-8 dihydrochloride | Inhibitor | 99.19% | Unkown |
| HY-121541 | CB-25 | 98.84% | Unkown | |
| HY-134598A | 653-47 hydrochloride | Inhibitor | 99.42% | Unkown |
| HY-148867 | UCM-1306 | Modulator | 99.49% | Unkown |
| HY-175231 | ST171 | Agonist | 99.34% | Unkown |
| HY-19026 | Siguazodan | Inhibitor | 99.06% | Unkown |
| HY-P10728 | B7-33 | 99.31% | Unkown | |
| HY-P1250 | RFRP-3(human) | Agonist | 99.43% | Unkown |
| HY-P2197 | ELA-11(human) | 99.54% | Unkown | |
| HY-100656AS | Desmethyl cariprazine-d8 | 99.93% | Unkown | |
| HY-123650 | FSBA hydrochloride | 99.06% | Unkown | |
| HY-131768 | 2'-O-Succinyl-cAMP | 99.0% | Unkown | |
| HY-N0113B | Hordenine hydrochloride | Inhibitor | 99.82% | Unkown |
| HY-N11141 | (R)-Octopamine | Agonist | 95.22% | Unkown |
| HY-P0172 | ATI-2341 | Agonist | 99.64% | Unkown |
| HY-N0113S | Hordenine-d6 | Inhibitor | 98.03% | Unkown |
| HY-100530B | Sp-cAMPS | / | Unkown | |
| HY-103178 | MRE3008F20 | Antagonist | 99.70% | Unkown |
| HY-103565A | AMN082 free base | Agonist | 98.37% | Unkown |
| HY-106045 | Imazodan | Inhibitor | 99.38% | Unkown |
| HY-108623 | Atizoram | Inhibitor | 96.3% | Unkown |
| HY-108991 | T-0509 | Agonist | 98.01% | Unkown |
| HY-110040 | L759633 | Agonist | 99.9% | Unkown |
| HY-132993 | Hcyb1 | Inhibitor | 98.20% | Unkown |
| HY-137640A | Sp-8-Br-cAMPS sodium | Agonist | 99.9% | Unkown |
| HY-153213A | Org 274178-0 | Antagonist | 99.40% | Unkown |
| HY-161405 | NPFF1-R antagonist 1 | Inhibitor | 99.38% | Unkown |
| HY-169792 | HPG1860 | 99.9% | Unkown | |
| HY-170788 | PDE7A-IN-1 | Inhibitor | 99.83% | Unkown |
| HY-182774 | YU241279 | Inhibitor | 99.58% | Unkown |
| HY-185107 | CTR/AMYR modulator-2 | Agonist | / | Unkown |
| HY-N0126R | Xanthone (Standard) | Inhibitor | 99.99% | Unkown |
| HY-P10927A | BRP TFA | / | Unkown | |
| HY-P2249 | ELA-21 (human) | 99.97% | Unkown | |
| HY-P2285 | AC 253 | Antagonist | 98.54% | Unkown |
| HY-P4665 | Ac-c[Cys-Glu-His-d-Phe-Arg-Trp-d-Cys]-Pro-Pro-Lys-Asp-NH2 | Antagonist | 98.14% | Unkown |
| HY-P6292 | KS-133 | 98.75% | Unkown | |
| HY-W040329S1 | 2'-Deoxyadenosine-13C10 | 99.0% | Unkown | |
| HY-137370 | 2-Hexynyl-5′-N-ethylcarboxamidoadenosine | 99.39% | Unkown | |
| HY-162394 | Vasopressin V2 receptor antagonist 2 | Antagonist | 99.81% | Unkown |
| HY-P10256A | Kiss2 peptide acetate | Activator | / | Unkown |
| HY-112612 | RTI-13951-33 | / | Unkown | |
| HY-100013 | 2-PCCA | Agonist | / | Unkown |
| HY-100013B1 | (1S,2S)-2-PCCA hydrochloride | Control | 99.65% | Unkown |
| HY-100530 | Rp-cAMPS triethylammonium salt | Antagonist | 99.9% | Unkown |
| HY-101317 | TAN-67 dihydrobromide | Agonist | 99.20% | Unkown |
| HY-103172 | 8-Aminoadenine | Inhibitor | 98.34% | Unkown |
| HY-103369 | PG01 | Activator | 98.04% | Unkown |
| HY-106739 | Motapizone | Inhibitor | 95.0% | Unkown |
| HY-108258 | PSN 375963 | Agonist | 99.95% | Unkown |
| HY-108621 | RS-25344 hydrochloride | Inhibitor | 99.93% | Unkown |
| HY-113689 | GAT211 | Agonist | 99.96% | Unkown |
| HY-114727 | PDE7-IN-4 | 98.55% | Unkown | |
| HY-115553 | DETQ | Agonist | / | Unkown |
| HY-120246 | GS-5759 | 99.21% | Unkown | |
| HY-120826 | A2AAR/hMAO-B-IN-1 | Inhibitor | 99.0% | Unkown |
| HY-120994 | Rp-8-CPT-cAMPS sodium | Antagonist | ≥99.0% | Unkown |
| HY-123335 | L-796778 | Agonist | 98.00% | Unkown |
| HY-123396 | 8-Chloro-cAMP | Modulator | 99.84% | Unkown |
| HY-125382A | L-797591 hydrochloride | Agonist | 99.81% | Unkown |
| HY-125957 | A-3 hydrochloride | Inhibitor | 99.75% | Unkown |
| HY-131032 | KI-7 | Agonist | 99.16% | Unkown |
| HY-132240 | SF-22 | Antagonist | 99.49% | Unkown |
| HY-134254 | 8-AHA-cAMP | 99.0% | Unkown | |
| HY-136974 | 9-Deoxyforskolin | 98.16% | Unkown | |
| HY-141495 | (Rac)-Razpipadon | Agonist | 97.09% | Unkown |
| HY-14296A | PF-610355 (hydrochloride) | Agonist | / | Unkown |
| HY-151392 | LPA5 antagonist 2 | Antagonist | 99.62% | Unkown |
| HY-156772 | GPR88 agonist 2 | Agonist | 99.57% | Unkown |
| HY-160921 | Capeserod | Agonist | 98.66% | Unkown |
| HY-167856 | RTI-122 | Agonist | / | Unkown |
| HY-173178 | LNS8801 | Agonist | / | Unkown |
| HY-182638 | CPL500036 | / | Unkown | |
| HY-401913 | endo CNTinh-03 | Inhibitor | 99.96% | Unkown |
| HY-N12378 | β-Patchoulene | 96.88% | Unkown | |
| HY-N6901 | Luteolin 7-sulfate | ≥95.0% | Unkown | |
| HY-N8092 | Kushenol B | Inhibitor | 96% | Unkown |
| HY-P1597 | Malantide | 98.04% | Unkown | |
| HY-P2197A | ELA-11(human) TFA | Chemical | 99.03% | Unkown |
| HY-P2867 | Phosphodiesterase II, Bovine Spleen | / | Unkown | |
| HY-P3570 | Adipokinetic hormone II (Locusta migratoria) | Inducer | 99.58% | Unkown |
| HY-P4890A | Relaxin H3 (human) TFA | / | Unkown | |
| HY-P99004 | hMC1R agonist 1 | Antagonist | / | Unkown |
| HY-Q40876 | BBT | Modulator | 99.71% | Unkown |
| HY-RS01870 | CAMP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-113513 | 5-HEPE | 98.01% | Unkown | |
| HY-121837 | β2AR-IN-15 | Antagonist | 98.84% | Unkown |
| HY-134395 | 6-MB-cAMP | / | Unkown | |
| HY-137308 | 15(R)-Prostaglandin D2 | 99.9% | Unkown | |
| HY-16900R | Rolipram (Standard) | Inhibitor | 99.24% | Unkown |
| HY-171591 | SIK2-IN-4 | Inhibitor | 99.06% | Unkown |
| HY-43934 | Tiropramide hydrochloride | Inhibitor | / | Unkown |
| HY-N2452 | Cochinchinenin C | Agonist | / | Unkown |
| HY-130304 | 8-Isoprostaglandin E2 | Activator | 98.31% | Unkown |
| HY-15371G | Forskolin (GMP) | / | Unkown | |
| HY-P4863 | Biotinyl-Amylin (human) | Agonist | 98.75% | Unkown |
| HY-106358A | Andolast | Inhibitor | / | Unkown |
| HY-119236 | CP-432 | / | Unkown | |
| HY-123534A | CYT-1010 hydrochloride | Agonist | / | Unkown |
| HY-126250 | NPD-1335 | Inhibitor | 98.10% | Unkown |
| HY-165456 | AGN-190851 | / | Unkown | |
| HY-184213 | INCB106385 | Antagonist | / | Unkown |
| HY-100530A | Rp-cAMPS | Antagonist | / | Unkown |
| HY-100984A | HA-100 hydrochloride | Inhibitor | / | Unkown |
| HY-101189B | JNJ-39758979 dihydrochloride | Antagonist | / | Unkown |
| HY-101826A | ER21355 hydrochloride | Inhibitor | / | Unkown |
| HY-101863 | CB-6673567 | Inhibitor | / | Unkown |
| HY-105118 | Zaldaride | Inhibitor | / | Unkown |
| HY-105482 | BMY 20844 | Inhibitor | / | Unkown |
| HY-105517 | MDL 27032 | Inhibitor | / | Unkown |
| HY-105912 | ONO 1082 | / | Unkown | |
| HY-105931 | Lixazinone | Inhibitor | / | Unkown |
| HY-106045A | Imazodan hydrochloride | Inhibitor | / | Unkown |
| HY-106893 | Pimilprost | Agonist | / | Unkown |
| HY-107506 | Ro 67-4853 | Agonist | 99.90% | Unkown |
| HY-107612 | GPBAR-A | Agonist | / | Unkown |
| HY-108258A | PSN 375963 hydrochloride | Agonist | / | Unkown |
| HY-108648A | 2-MeSADP | Agonist | / | Unkown |
| HY-110005 | Sp-cAMPS triethylamine | / | Unkown | |
| HY-110070 | DL-AP4 sodium | Agonist | / | Unkown |
| HY-110161 | sst2 Receptor agonist-1 | Agonist | / | Unkown |
| HY-11032 | SM-350300 | / | Unkown | |
| HY-110366 | WAY-181187 oxalate | Agonist | / | Unkown |
| HY-112363 | Aloisine A | / | Unkown | |
| HY-112631 | OPC 33540 | Inhibitor | / | Unkown |
| HY-113243 | 1-Oleoyl lysophosphatidylcholine | Activator | / | Unkown |
| HY-113781 | Ractopamine | Agonist | / | Unkown |
| HY-113822 | Lixazinone hydrogensulfate | Inhibitor | / | Unkown |
| HY-113918 | SW-106 | Antagonist | / | Unkown |
| HY-114052 | NVP-ABE171 | Inhibitor | / | Unkown |
| HY-114539 | L-750667 triHydrochloride | Antagonist | 99.39% | Unkown |
| HY-114990 | EMD 57439 | Inhibitor | / | Unkown |
| HY-115643 | AZ13581837 | / | Unkown | |
| HY-115769 | 1,2-Didecanoylglycerol | Activator | / | Unkown |
| HY-116119 | BDF 9148 | Activator | / | Unkown |
| HY-116295 | MRS2690 | / | Unkown | |
| HY-116295A | MRS2690 disodium | / | Unkown | |
| HY-116312 | 8-pCPT-2′-O-Me-cAMP | Activator | / | Unkown |
| HY-116445 | UNC9975 | Agonist | / | Unkown |
| HY-116540 | L 858051 | Activator | / | Unkown |
| HY-116540A | L 858051 dihydrochloride | Activator | / | Unkown |
| HY-116755S2 | Tiropramide-d5 oxalate | Inhibitor | / | Unkown |
| HY-116806 | AF-2785 | Inhibitor | / | Unkown |
| HY-117181 | UK-1745 | Inhibitor | / | Unkown |
| HY-117694 | MK-8825 | Antagonist | / | Unkown |
| HY-117715 | CK-3197 | Inhibitor | / | Unkown |
| HY-118175 | RG 14921 | Inhibitor | / | Unkown |
| HY-119114 | E-2508 free base | Antagonist | / | Unkown |
| HY-119247 | NBI 30545 | Antagonist | / | Unkown |
| HY-119708A | Ensifentrine tosylate | Inhibitor | / | Unkown |
| HY-120093 | GAT100 | / | Unkown | |
| HY-120195 | PF-04677490 | Inhibitor | / | Unkown |
| HY-120684 | PDE10-IN-6 | Inhibitor | / | Unkown |
| HY-120687 | A68930 | Agonist | / | Unkown |
| HY-120879 | PF2562 | Agonist | / | Unkown |
| HY-120994A | Rp-8-CPT-cAMPS | Antagonist | / | Unkown |
| HY-120994B | Sp-8-CPT-cAMPS | Activator | / | Unkown |
| HY-121041 | GEBR-7b | / | Unkown | |
| HY-121249 | Capeserod hydrochloride | Agonist | / | Unkown |
| HY-122189 | Akuammine | / | Unkown | |
| HY-122622 | PF-04471141 hydrochloride | Inhibitor | / | Unkown |
| HY-123008 | Reproterol hydrochloride | / | Unkown | |
| HY-123782 | (Rac)-UK-414495 | Inhibitor | / | Unkown |
| HY-124381 | ML10375 | Modulator | / | Unkown |
| HY-124635 | BC-54 | / | Unkown | |
| HY-125020 | NCGC00135472 | Activator | / | Unkown |
| HY-12520 | SKF 38393 | / | Unkown | |
| HY-12525B | LGD 6972 ammonium | Antagonist | / | Unkown |
| HY-125646 | YH18968 | Activator | / | Unkown |
| HY-126754 | Archangelicin | Inhibitor | / | Unkown |
| HY-12880 | HA-100 dihydrochloride | Inhibitor | / | Unkown |
| HY-129089 | (-)-MDO-NPA | Ligand | / | Unkown |
| HY-129210 | KMUP-4 | / | Unkown | |
| HY-129658 | TT-OAD2 free base | Agonist | / | Unkown |
| HY-129980A | NPC-15437 | / | Unkown | |
| HY-130176 | UFP-512 | / | Unkown | |
| HY-130629 | VHC-7 | Agonist | / | Unkown |
| HY-131772 | 2-AHA-cAMP | / | Unkown | |
| HY-133151 | CXCR6 antagonist 1 | Antagonist | / | Unkown |
| HY-134263 | 8-Br-cAMP-AM | Agonist | / | Unkown |
| HY-134264 | 8-Br-2'-O-Me-cAMP | Activator | / | Unkown |
| HY-134283 | 8-Benzylthio-cAMP | Activator | / | Unkown |
| HY-134298 | 8-CPT-6-Phe-cAMP | Activator | / | Unkown |
| HY-134321 | 8-Azido-cAMP | / | Unkown | |
| HY-134340 | 8-pMeOPT-2'-O-Me-cAMP | Activator | / | Unkown |
| HY-134598 | 653-47 | Inhibitor | / | Unkown |
| HY-135079 | Lerimazoline | Agonist | / | Unkown |
| HY-136501 | MRS2395 | Antagonist | / | Unkown |
| HY-13749S2 | Sitagliptin-d4 | Inhibitor | / | Unkown |
| HY-137638 | Sp-5,6-DCl-cBIMPS | Activator | / | Unkown |
| HY-137638A | Sp-5,6-DCl-cBIMPS sodium | Activator | / | Unkown |
| HY-137640B | Rp-8-Br-cAMPS | Inhibitor | / | Unkown |
| HY-139486 | AM-8123 | Agonist | 99.89% | Unkown |
| HY-14132 | BMS-665053 | Antagonist | / | Unkown |
| HY-142972 | 19(S)-HETE | Agonist | / | Unkown |
| HY-14300AS | Vilanterol-d4 trifenatate | Agonist | / | Unkown |
| HY-14300D | Vilanterol acetate | Agonist | / | Unkown |
| HY-14302S1 | Salmeterol-d5 | Agonist | / | Unkown |
| HY-14326 | L-750667 | Ligand | 99.26% | Unkown |
| HY-14341 | E-6837 | Ligand | / | Unkown |
| HY-144705 | GAT564 | Modulator | / | Unkown |
| HY-145156 | CHU-128 | Agonist | / | Unkown |
| HY-14773S | (Rac)-Mirabegron-d5 | Agonist | / | Unkown |
| HY-147751 | APJ receptor agonist 6 | / | Unkown | |
| HY-147946 | PDE1-IN-4 | Inhibitor | / | Unkown |
| HY-148032 | 5-Benzyloxytryptamine | Agonist | / | Unkown |
| HY-148827 | GEM-231 | Inhibitor | / | Unkown |
| HY-148827A | GEM-231 sodium | Inhibitor | / | Unkown |
| HY-149168 | PF-4211 | Agonist | / | Unkown |
| HY-149247 | Antipsychotic agent-2 | / | Unkown | |
| HY-149933 | AM841 | Activator | / | Unkown |
| HY-150056 | CB1R Allosteric modulator 3 | 98.05% | Unkown | |
| HY-150057 | CB1R Allosteric modulator 4 | Modulator | / | Unkown |
| HY-150073 | DS01080522 | Inhibitor | / | Unkown |
| HY-153542 | AP-C6 | Inhibitor | / | Unkown |
| HY-153660A | Bivamelagon hydrochloride | Agonist | / | Unkown |
| HY-153660S | Bivamelagon-d8 | Agonist | / | Unkown |
| HY-15498S | Rimegepant-d4 | Antagonist | / | Unkown |
| HY-156434 | PDE11A4-IN-1 | Inhibitor | / | Unkown |
| HY-156536 | RXFP1 receptor agonist-1 | / | Unkown | |
| HY-156537 | RXFP1 receptor agonist-2 | / | Unkown | |
| HY-156538 | RXFP1 receptor agonist-3 | / | Unkown | |
| HY-156539 | RXFP1 receptor agonist-4 | / | Unkown | |
| HY-156540 | RXFP1 receptor agonist-5 | / | Unkown | |
| HY-156541 | RXFP1 receptor agonist-6 | / | Unkown | |
| HY-156542 | RXFP1 receptor agonist-7 | / | Unkown | |
| HY-156543 | RXFP1 receptor agonist-8 | / | Unkown | |
| HY-158179 | A3AR agonist 3 | Agonist | / | Unkown |
| HY-158180 | A3AR agonist 4 | Agonist | / | Unkown |
| HY-158181 | A3AR agonist 5 | Agonist | / | Unkown |
| HY-159917 | PPL agonist-1 | / | Unkown | |
| HY-159920 | PSB-22269 | Antagonist | / | Unkown |
| HY-159942 | 5-HT7R antagonist 3 | / | Unkown | |
| HY-160864 | Torbafylline | Inhibitor | / | Unkown |
| HY-161107 | OX04529 | Agonist | / | Unkown |
| HY-161506 | PDE1-IN-7 | Inhibitor | / | Unkown |
| HY-161817 | TGR5 agonist 5 | Agonist | / | Unkown |
| HY-162401 | AZ7976 | Agonist | / | Unkown |
| HY-162581 | FCPR16 | Inhibitor | / | Unkown |
| HY-162787 | Adenosine receptor antagonist 5 | Antagonist | / | Unkown |
| HY-163345 | 5-HT7R antagonist 2 | Antagonist | / | Unkown |
| HY-163530 | GPR41 modulator 1 | Modulator | / | Unkown |
| HY-163651 | (R)-Vorbipiprant | Antagonist | / | Unkown |
| HY-165436 | Toborinone | Inhibitor | / | Unkown |
| HY-168481 | GLP-1R agonist 27 | Agonist | / | Unkown |
| HY-168558 | PDE4B/D-IN-4 | Inhibitor | / | Unkown |
| HY-16900G | Rolipram (GMP) | Inhibitor | / | Unkown |
| HY-169833 | BL 6341A | Antagonist | / | Unkown |
| HY-169963 | PDE1-IN-8 | Inhibitor | / | Unkown |
| HY-170431 | SAL-0010042 | Inhibitor | / | Unkown |
| HY-170908 | Pellotine | Antagonist | / | Unkown |
| HY-170948 | A2AR modulator-1 | Modulator | / | Unkown |
| HY-171069 | FFA2 agonist-1 | Agonist | / | Unkown |
| HY-171302 | GLP-1R/GIPR agonist-2 | Agonist | / | Unkown |
| HY-171590 | SIK2-IN-3 | Inhibitor | / | Unkown |
| HY-171850 | GLP-1R modulator-1 | Agonist | / | Unkown |
| HY-171851 | GLP-1R agonist 32 | Agonist | / | Unkown |
| HY-171909 | Glycerophosphoinositol 4-phosphate | / | Unkown | |
| HY-171909A | Glycerophosphoinositol 4-phosphate disodium | / | Unkown | |
| HY-173044 | 5-HT1AR/5-HT6R ligand-1 | / | Unkown | |
| HY-173290 | PDE4D inhibitor 1 | Inhibitor | / | Unkown |
| HY-173360 | PDE10A-IN-5 | Inhibitor | / | Unkown |
| HY-173479 | GLP-1R agonist 30 | Agonist | / | Unkown |
| HY-17453S | Salmeterol-d3 xinafoate | Agonist | / | Unkown |
| HY-17453S1 | Salmeterol-13C6 xinafoate | Agonist | / | Unkown |
| HY-174986 | CGRP antagonist 7 | Antagonist | / | Unkown |
| HY-175001 | D1/D5 Receptor agonist-1 | Inhibitor | / | Unkown |
| HY-175195 | Adenosine receptor antagonist 6 | / | Unkown | |
| HY-175483S | TrkB activator-1 | Activator | / | Unkown |
| HY-175486 | KOR agonist 6 | Agonist | / | Unkown |
| HY-175666 | ISAM-CG557 | / | Unkown | |
| HY-175982 | AURKA-IN-3 | Inhibitor | / | Unkown |
| HY-176493 | GLP-1R agonist 33 | Agonist | / | Unkown |
| HY-176504 | Adenosine receptor agonist 2 | Agonist | / | Unkown |
| HY-176520 | PDE4-IN-29 | Inhibitor | / | Unkown |
| HY-177122 | Raxlaprazine etomoxil | Modulator | / | Unkown |
| HY-177493A | SSTR3 agonist-1 TFA | Agonist | / | Unkown |
| HY-178103 | D1R antagonist 2 | Antagonist | / | Unkown |
| HY-178203 | AM12814 | Agonist | / | Unkown |
| HY-178478 | PDE1-IN-11 | Inhibitor | 99.24% | Unkown |
| HY-178780 | MKP10241 | Agonist | 98.06% | Unkown |
| HY-178783 | MRS8454 | Modulator | / | Unkown |
| HY-178982 | Apelin agonist 2 | Agonist | / | Unkown |
| HY-179240 | UNC9815 | Modulator | / | Unkown |
| HY-179241 | UNC10062 | Modulator | / | Unkown |
| HY-179248 | Adenosine receptor antagonist 7 | / | Unkown | |
| HY-179407 | LT-104A | Inhibitor | / | Unkown |
| HY-179471 | PSB-17365 | Agonist | / | Unkown |
| HY-179504 | PDE4B-IN-6 | Inhibitor | / | Unkown |
| HY-179645 | Phosphodiesterase-IN-5 | / | Unkown | |
| HY-179724 | PZ-1657 | Inhibitor | / | Unkown |
| HY-179724A | PZ-1657 hydrochloride | Inhibitor | / | Unkown |
| HY-179725 | PZ-1129 | Ligand | / | Unkown |
| HY-180142 | XYDC2050 | Antagonist | / | Unkown |
| HY-180198 | UCM1400 | / | Unkown | |
| HY-180300 | N6-Ethoxycarbonyl-cAMP | / | Unkown | |
| HY-180372 | CSP-2503 | Agonist | / | Unkown |
| HY-181047 | FMJ-01-042 | Agonist | / | Unkown |
| HY-181049 | FMJ-01-054 | Antagonist | / | Unkown |
| HY-181088 | PDE3/4-IN-4 | Inhibitor | / | Unkown |
| HY-181571 | PDE4-IN-33 | Inhibitor | / | Unkown |
| HY-181589 | PDE11A4-IN-2 | Inhibitor | / | Unkown |
| HY-181738 | GPR17 agonist 2 | / | Unkown | |
| HY-181822 | BMS-986331 | / | Unkown | |
| HY-181956 | MPAM-15 | Modulator | / | Unkown |
| HY-182011 | GPR6 inverse agonist 2 | Agonist | / | Unkown |
| HY-182414 | NCO-650 free base | Inhibitor | / | Unkown |
| HY-182415 | RX-RA-69 | Inhibitor | / | Unkown |
| HY-182452 | U 84569 | Inhibitor | / | Unkown |
| HY-182453 | RM1490 | Modulator | / | Unkown |
| HY-182473 | AL-6556 | Agonist | / | Unkown |
| HY-182502 | GLP-1R-agonist-43 | Agonist | / | Unkown |
| HY-182503 | GP515 | Inhibitor | / | Unkown |
| HY-182580 | HBK001 | / | Unkown | |
| HY-182640 | SM-11044 | Agonist | / | Unkown |
| HY-182645 | CRF1 receptor antagonist-2 | Antagonist | / | Unkown |
| HY-182705 | Org 214444-0 | / | Unkown | |
| HY-182714 | N 0840 | Antagonist | / | Unkown |
| HY-182850 | UCUF-965 | Modulator | / | Unkown |
| HY-182905 | SSTR5/TGR5-modulator-1 | Modulator | / | Unkown |
| HY-183657A | GPR3 inverse agonist-1 TFA | / | Unkown | |
| HY-183693 | GLP-1 receptor agonist 21 | Agonist | / | Unkown |
| HY-183694 | GLP-1 receptor agonist 22 | Agonist | / | Unkown |
| HY-183734 | Obuprazine | / | Unkown | |
| HY-184192 | R-185 | Agonist | / | Unkown |
| HY-184208 | MCL-524 | Agonist | / | Unkown |
| HY-185289 | Methoxyfenoterol | / | Unkown | |
| HY-185643 | PF-04475270 | Agonist | / | Unkown |
| HY-186020 | L-4-Aminoarabinose-bactoprenyl phosphate | / | Unkown | |
| HY-186104 | AMYR/CTR agonist 1 | Agonist | / | Unkown |
| HY-186200 | PTHR1 antagonist 1 | Antagonist | / | Unkown |
| HY-186214 | PDE4-IN-36 | Inhibitor | / | Unkown |
| HY-19436A | Solabegron hydrochloride | Agonist | / | Unkown |
| HY-69172 | RS-25344 | Inhibitor | / | Unkown |
| HY-B0531S | Triflusal-d3 | / | Unkown | |
| HY-B1505G | Acefylline (GMP) | / | Unkown | |
| HY-B1511G | Cyclic AMP (GMP) | / | Unkown | |
| HY-D1187 | 2-Aza-ε-cAMP | / | Unkown | |
| HY-D1187A | 2-Aza-ε-cAMP sodium | / | Unkown | |
| HY-N0113A | Hordenine sulfate | / | Unkown | |
| HY-N0113R | Hordenine (Standard) | Inhibitor | / | Unkown |
| HY-N1189 | DL-Syringaresinol diacetate | / | Unkown | |
| HY-N13132 | Hellicoside | Inhibitor | / | Unkown |
| HY-N14663 | Griseolic acid C | Inhibitor | / | Unkown |
| HY-N19773 | (S)-Mansonone E | / | Unkown | |
| HY-N2658 | 5,7-Diacetoxy-8-methoxyflavone | Inhibitor | 98.04% | Unkown |
| HY-N3324 | Mangostanol | Inhibitor | / | Unkown |
| HY-N3464 | Isopedicin | Inhibitor | / | Unkown |
| HY-N3550 | Catalponol | / | Unkown | |
| HY-N3773 | Dodoviscin A | Inhibitor | / | Unkown |
| HY-N6256 | Ilexsaponin B2 | Inhibitor | / | Unkown |
| HY-N8593S | Undecane-d24 | / | Unkown | |
| HY-P0036A | Octreotide dihydrochloride | / | Unkown | |
| HY-P0221A | PACAP (1-38), human, ovine, rat TFA | Inducer | / | Unkown |
| HY-P0222A | PKI(5-24) TFA | Inhibitor | / | Unkown |
| HY-P0252B | α-MSH free acid | Agonist | / | Unkown |
| HY-P10047 | PKItide | Inhibitor | / | Unkown |
| HY-P10256 | Kiss2 peptide | Activator | / | Unkown |
| HY-P1065A | Apelin-36(rat, mouse) TFA | / | Unkown | |
| HY-P10924 | Roseltide rT1 | Inhibitor | / | Unkown |
| HY-P11246 | A13:B7-24-GG | Agonist | / | Unkown |
| HY-P11275 | TC4 | Agonist | / | Unkown |
| HY-P11279 | TC2 | Agonist | / | Unkown |
| HY-P11586 | San45 | Agonist | / | Unkown |
| HY-P11818 | GIPR/GLP-1R/GCGR agonist-1 | / | Unkown | |
| HY-P11880 | LY3324954 | Agonist | / | Unkown |
| HY-P11881 | IUB288 | / | Unkown | |
| HY-P1250A | RFRP-3(human) TFA | Agonist | / | Unkown |
| HY-P1296A | Urocortin, rat TFA | Agonist | / | Unkown |
| HY-P1298 | Sauvagine | Agonist | / | Unkown |
| HY-P1325 | BWX 46 | Agonist | / | Unkown |
| HY-P1471A | Adrenomedullin (AM) (22-52), human TFA | Antagonist | / | Unkown |
| HY-P1595A | CREBtide TFA | Substrate | 98.72% | Unkown |
| HY-P1597A | Malantide TFA | / | Unkown | |
| HY-P1817 | PACAP-38 (16-38), human, mouse, rat | / | Unkown | |
| HY-P1913 | Calcitonin Gene Related Peptide II (rat) | Activator | / | Unkown |
| HY-P3419A | PAMP-12 (unmodified) TFA | Agonist | / | Unkown |
| HY-P3544 | Lys-[Hyp3]-Bradykinin | Agonist | / | Unkown |
| HY-P3572 | Adipokinetic hormone I (Locusta migratoria) | Inducer | 99.88% | Unkown |
| HY-P3770 | Phosphate acceptor peptide | Inhibitor | / | Unkown |
| HY-P3786 | H-Arg-Gly-Tyr-Ala-Leu-Gly-OH | Inhibitor | / | Unkown |
| HY-P3930 | PKI (5-24),amide | Inhibitor | / | Unkown |
| HY-P4497 | Prolylserine | / | Unkown | |
| HY-P4817 | Human PTH-(1-31) | / | Unkown | |
| HY-P4890 | Relaxin H3 (human) | / | Unkown | |
| HY-P5757 | (D-Trp32)-Neuropeptide Y (porcine) | Agonist | / | Unkown |
| HY-P5950 | ACTH (6-24) (human) | Inhibitor | / | Unkown |
| HY-RS02596 | CHAMP1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W011683S | 2'-Deoxyadenosine monohydrate-1′-13C | / | Unkown | |
| HY-W011683S1 | 2'-Deoxyadenosine monohydrate-2′-13C | / | Unkown | |
| HY-W011683S2 | 2'-Deoxyadenosine monohydrate-3′-13C | / | Unkown | |
| HY-W011683S3 | 2'-Deoxyadenosine monohydrate-5′-13C | / | Unkown | |
| HY-W011683S6 | 2'-Deoxyadenosine monohydrate-13C10,15N5 hydrate | 99.7% | Unkown | |
| HY-W040329S | 2'-Deoxyadenosine-13C10,15N5 | / | Unkown | |
| HY-W040329S3 | 2'-Deoxyadenosine-15N5,d13 | / | Unkown | |
| HY-W127485 | cis-9,10-Methyleneoctadecanoic Acid | / | Unkown | |
| HY-W349178 | Medorinone | Inhibitor | / | Unkown |
| HY-W664041 | Noncatechol agonist-1 | / | Unkown | |
| HY-W673613 | ADX68692 | Inhibitor | / | Unkown |
| HY-W745905 | 2'-Deoxyadenosine-15N1 | / | Unkown | |
| HY-W746031 | WAY-181187 hydrochloride | Agonist | / | Unkown |
| HY-100543R | Zenidolol (Standard) | / | Unkown | |
| HY-101987A | (Rac)-BW 245C | Agonist | / | Unkown |
| HY-106830 | Pelrinone | Inhibitor | / | Unkown |
| HY-113402AR | Gamma-glutamylcysteine TFA (Standard) | / | Unkown | |
| HY-113402B | Gamma-glutamylcysteine ammonium | / | Unkown | |
| HY-117064 | NY-0173 | Antagonist | / | Unkown |
| HY-119333 | NNC 11-1607 | Agonist | / | Unkown |
| HY-123396A | 8-Chloro-cAMP sodium | Modulator | / | Unkown |
| HY-12366S | Ubrogepant-d5 | Antagonist | / | Unkown |
| HY-124681 | NY0116 | Agonist | / | Unkown |
| HY-12525A | LGD-6972 sodium | Antagonist | / | Unkown |
| HY-125382 | L-797591 | Agonist | / | Unkown |
| HY-129474 | MP 518 | Inhibitor | / | Unkown |
| HY-131421 | 8-PIP-cAMP | Activator | / | Unkown |
| HY-131664 | EP3 antagonist 2 | Antagonist | / | Unkown |
| HY-131764 | 2'-O-MB-cGMP sodium | Inhibitor | / | Unkown |
| HY-131766 | 2'-O-Me-cAMP | Activator | / | Unkown |
| HY-131777 | 2-Cl-cAMP | Agonist | / | Unkown |
| HY-131823 | 5,6-DCl-cBIMP | Agonist | / | Unkown |
| HY-131824 | 5,6-DM-cBIMP | Agonist | / | Unkown |
| HY-131842 | 6-Bn-cAMP | Activator | / | Unkown |
| HY-131844 | 6-Bnz-5'-AMP | / | Unkown | |
| HY-134299 | 8-CPT-cAMP-AM | Activator | / | Unkown |
| HY-134302 | 8-HA-cAMP | Activator | / | Unkown |
| HY-134308 | 8-NBD-cAMP sodium | / | Unkown | |
| HY-134325 | 8-OH-cAMP | Agonist | / | Unkown |
| HY-134332 | 8-pCPT-5'-AMP | Activator | / | Unkown |
| HY-134348 | 8-pHPT-2'-O-Me-cAMP | Agonist | / | Unkown |
| HY-134389 | 6-Phe-cAMP | Activator | / | Unkown |
| HY-134406 | 6-Cl-cPuMP sodium | Modulator | / | Unkown |
| HY-136942 | DS1 | Agonist | / | Unkown |
| HY-137381 | 6-Bnz-cAMP | / | Unkown | |
| HY-13749S3 | Sitagliptin-d6 | Inhibitor | / | Unkown |
| HY-137530 | 8-MA-cAMP | Agonist | / | Unkown |
| HY-137624 | Sp-cAMPS-AM | Activator | / | Unkown |
| HY-137628 | Sp-8-PIP cAMP | Agonist | / | Unkown |
| HY-137630 | Sp-8-pCPT-2'-O-Me-cAMPS | Activator | / | Unkown |
| HY-137632 | Sp-8-Cl-cAMPS | / | Unkown | |
| HY-137635 | Sp-6-Phe-cAMPS | Activator | / | Unkown |
| HY-137640 | Sp-8-Br-cAMPS | Agonist | / | Unkown |
| HY-137641 | Sp-8-Br-2'-O-Me-cAMPS | Activator | / | Unkown |
| HY-148596 | UDP-GlcNAc | / | Unkown | |
| HY-156925 | PKA/AKAP-IN-1 | Inhibitor | / | Unkown |
| HY-157010 | AP736 | Inhibitor | / | Unkown |
| HY-165553 | ASB16165 | Inhibitor | / | Unkown |
| HY-165568 | OPC 3911 | / | Unkown | |
| HY-167201 | 2ccPA | Inhibitor | / | Unkown |
| HY-170970 | Mtb-IN-10 | Inhibitor | / | Unkown |
| HY-172411 | GLP-1R agonist 29 | Agonist | / | Unkown |
| HY-179376 | Anti-virulence factor-IN-3 | Inhibitor | / | Unkown |
| HY-179518 | Antifungal agent 140 | Inhibitor | / | Unkown |
| HY-179728 | Amylin agonist 1 | Agonist | / | Unkown |
| HY-180220 | GLP-1R agonist 40 | Agonist | / | Unkown |
| HY-180845 | TGR5 agonist 9 | Agonist | / | Unkown |
| HY-181102 | TGR5 agonist 10 | Agonist | / | Unkown |
| HY-181485 | GPR68 antagonist 1 | / | Unkown | |
| HY-183180 | CGRP antagonist-8 | Antagonist | / | Unkown |
| HY-183181 | CGRP antagonist-9 | Antagonist | / | Unkown |
| HY-183400 | BIM-46174 | / | Unkown | |
| HY-183455 | CI-930 | Inhibitor | / | Unkown |
| HY-183945 | WO-459 | Agonist | / | Unkown |
| HY-183973 | MTXPG5 | Inhibitor | / | Unkown |
| HY-19436S | Solabegron-d8 | Agonist | / | Unkown |
| HY-29268 | β-Carboline-1-carboxylic acid | Inhibitor | / | Unkown |
| HY-47412 | Cariprazine impurity 1 | Agonist | ≥98.0% | Unkown |
| HY-48289 | PKA/AKAP-IN-2 | Inhibitor | / | Unkown |
| HY-B0679S | Lubiprostone-d7 | / | Unkown | |
| HY-B0764G | Bucladesine sodium (GMP) | Activator | / | Unkown |
| HY-B1505A | Acefylline piperazine | / | Unkown | |
| HY-N14662 | Griseolic acid B | Inhibitor | / | Unkown |
| HY-N7648 | Atherosperminine | Inhibitor | / | Unkown |
| HY-N7648A | Atherosperminine hydrochloride | Inhibitor | / | Unkown |
| HY-P0036S2 | Octreotide-d8 | / | Unkown | |
| HY-P0036S3 | Octreotide-13C9,15N | / | Unkown | |
| HY-P0036S4 | Octreotide-d8 acetate | / | Unkown | |
| HY-RS22909 | Vamp5 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23258 | Camp Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W011683S7 | 2'-Deoxyadenosine monohydrate-15N5 | / | Unkown | |
| HY-W097929 | Tyrene | Inhibitor | ≥97.0% | Unkown |
| HY-W394717 | BGC-20-1531 | / | Unkown | |
| HY-W436495 | 6,15-Diketo-13,14-dihydro prostaglandin F1α | / | Unkown | |
| HY-W778207 | 2'-Deoxyadenosine-13C5 monohydrate | / | Unkown | |
| HY-P0036S | Octreotide-d8 TFA | / | Unkown | |
| HY-U00341 | ST4206 | Antagonist | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991202 | Anti-TSHR Antibody (M22) | 99.46% | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | CAMP | NCBI | NCBI:820 |
| Canis familiaris | CAMP | NCBI | NCBI:442947 |
| Macaca fascicularis | CAMP | NCBI | NCBI:102139204 |
| Mus musculus | CAMP | NCBI | NCBI:12796 |
| Rattus norvegicus | CAMP | NCBI | NCBI:316010 |